RGX-314 is a potential one-time gene therapy being investigated for the treatment of wet age-related macular degeneration (wet AMD), diabetic retinopathy (DR) and other chronic retinal diseases.
Type of MoleculeGene Therapy
Product TypeNew Indication
|Potential Indication||Region||Phase (1, 2, 3, Submitted)|
|Wet Age-related Macular Degeneration (wet AMD)||n/a||